Core Viewpoint - The article discusses the issuance of the "Quanzhou Modern Sports Products Advanced Manufacturing Industry Cluster Cultivation and Enhancement Three-Year Action Plan (2025-2027)", which aims to expand the sports equipment ecosystem and encourage innovation in personalized, customized, and intelligent product development [1] Group 1: Industry Development - The plan encourages companies to adapt to new consumer demands for fitness scene diversification and sports equipment segmentation [1] - It emphasizes the importance of "chain master" enterprises in targeting hot areas such as sports fitness equipment, outdoor sports gear, and lightweight ice and snow equipment [1] Group 2: Innovation and Product Focus - Companies are urged to increase investment in R&D for smart wearables, functional apparel, and rehabilitation equipment to explore new market segments [1] - The initiative aims to create a comprehensive ecosystem covering home fitness, professional training, and outdoor leisure, addressing all aspects of sports equipment from head to toe [1]

Group 1 - Xiangyu Medical has been focusing on the rehabilitation market for over 20 years, developing clinical rehabilitation equipment and integrated solutions based on specific clinical needs [1] - The company plans to launch more products and solutions in rehabilitation robotics, brain-computer interfaces, AI healthcare, mental health, and cardiopulmonary rehabilitation [1] Group 2 - Hualan Biological is evaluating various production expression systems for recombinant human albumin, including yeast, plant cell, and bacterial expression systems [2] - Currently, no domestic companies have obtained drug registration certificates for recombinant human albumin, which could alleviate the high reliance on imports if approved [2] Group 3 - Sanxin Medical identifies the ASEAN market as one of the most promising growth markets for blood dialysis globally, with significant sales achievements in countries like Indonesia, Malaysia, Thailand, and Vietnam [3] - The company aims to leverage multilateral economic cooperation mechanisms between China and ASEAN countries for further overseas market expansion [3] Group 4 - Renhe Pharmaceutical's outsourcing production aims to enrich the variety of products on the market, focusing on complementary products that the company does not have registration for or lacks production capacity [4] - All revenue and profits from outsourced products are reflected in the company's financial statements [4] Group 5 - Jinbo Biological has established partnerships with L'Oréal Group for raw material products, generating certain revenue [5] - The company is prioritizing market expansion in Southeast Asia while focusing on the speed of registration for medical devices [5] Group 6 - Guilin Sanjin's "Dizziness Ning" series sales surpassed 100 million yuan in 2021, with a target for double-digit growth this year [6] - The company is supporting second and third-tier products, which are showing better growth trends compared to first-tier products [6]